持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/12/23 | 4,595 | 4,595 | 4,565 | 4,575 | -25 | -0.5% | 20,800 |
2019/12/20 | 4,635 | 4,645 | 4,540 | 4,600 | +20 | +0.4% | 53,700 |
2019/12/19 | 4,585 | 4,610 | 4,535 | 4,580 | -10 | -0.2% | 50,500 |
2019/12/18 | 4,640 | 4,645 | 4,570 | 4,590 | -40 | -0.9% | 61,100 |
2019/12/17 | 4,560 | 4,630 | 4,530 | 4,630 | +120 | +2.7% | 52,000 |
2019/12/16 | 4,560 | 4,580 | 4,510 | 4,510 | -45 | -1% | 46,800 |
2019/12/13 | 4,570 | 4,625 | 4,550 | 4,555 | +50 | +1.1% | 102,600 |
2019/12/12 | 4,535 | 4,545 | 4,505 | 4,505 | -30 | -0.7% | 43,600 |
2019/12/11 | 4,550 | 4,565 | 4,520 | 4,535 | -15 | -0.3% | 50,600 |
2019/12/10 | 4,530 | 4,580 | 4,520 | 4,550 | +40 | +0.9% | 61,000 |
2019/12/09 | 4,505 | 4,520 | 4,430 | 4,510 | +35 | +0.8% | 34,800 |
2019/12/06 | 4,540 | 4,540 | 4,445 | 4,475 | -40 | -0.9% | 51,800 |
2019/12/05 | 4,510 | 4,540 | 4,500 | 4,515 | +25 | +0.6% | 55,200 |
2019/12/04 | 4,450 | 4,495 | 4,430 | 4,490 | +30 | +0.7% | 48,100 |
2019/12/03 | 4,485 | 4,495 | 4,435 | 4,460 | -15 | -0.3% | 55,900 |
2019/12/02 | 4,445 | 4,485 | 4,440 | 4,475 | +75 | +1.7% | 39,700 |
2019/11/29 | 4,455 | 4,460 | 4,400 | 4,400 | -30 | -0.7% | 42,900 |
2019/11/28 | 4,450 | 4,450 | 4,400 | 4,430 | -30 | -0.7% | 45,200 |
2019/11/27 | 4,460 | 4,500 | 4,460 | 4,460 | +15 | +0.3% | 46,000 |
2019/11/26 | 4,480 | 4,480 | 4,440 | 4,445 | +5 | +0.1% | 50,000 |
2019/11/25 | 4,465 | 4,480 | 4,410 | 4,440 | +15 | +0.3% | 30,200 |
2019/11/22 | 4,425 | 4,465 | 4,380 | 4,425 | ±0 | ±0% | 56,900 |
2019/11/21 | 4,440 | 4,470 | 4,350 | 4,425 | -35 | -0.8% | 43,400 |
2019/11/20 | 4,430 | 4,465 | 4,400 | 4,460 | +40 | +0.9% | 55,400 |
2019/11/19 | 4,380 | 4,430 | 4,375 | 4,420 | +40 | +0.9% | 45,200 |
2019/11/18 | 4,350 | 4,385 | 4,345 | 4,380 | +15 | +0.3% | 51,300 |
2019/11/15 | 4,325 | 4,380 | 4,325 | 4,365 | +65 | +1.5% | 55,400 |
2019/11/14 | 4,345 | 4,345 | 4,290 | 4,300 | -30 | -0.7% | 46,200 |
2019/11/13 | 4,390 | 4,395 | 4,330 | 4,330 | -45 | -1% | 54,700 |
2019/11/12 | 4,340 | 4,380 | 4,325 | 4,375 | +30 | +0.7% | 49,800 |
2019/11/11 | 4,380 | 4,415 | 4,345 | 4,345 | -15 | -0.3% | 42,400 |
2019/11/08 | 4,400 | 4,400 | 4,325 | 4,360 | -15 | -0.3% | 77,000 |
2019/11/07 | 4,415 | 4,420 | 4,360 | 4,375 | -25 | -0.6% | 61,300 |
2019/11/06 | 4,445 | 4,445 | 4,300 | 4,400 | +10 | +0.2% | 84,200 |
2019/11/05 | 4,325 | 4,465 | 4,265 | 4,390 | +150 | +3.5% | 125,700 |
2019/11/01 | 4,300 | 4,300 | 4,220 | 4,240 | -100 | -2.3% | 51,500 |
2019/10/31 | 4,350 | 4,405 | 4,295 | 4,340 | -5 | -0.1% | 86,800 |
2019/10/30 | 4,275 | 4,350 | 4,265 | 4,345 | +100 | +2.4% | 143,300 |
2019/10/29 | 4,275 | 4,280 | 4,220 | 4,245 | +20 | +0.5% | 75,800 |
2019/10/28 | 4,265 | 4,265 | 4,185 | 4,225 | -35 | -0.8% | 50,900 |
2019/10/25 | 4,215 | 4,260 | 4,185 | 4,260 | +75 | +1.8% | 66,700 |
2019/10/24 | 4,220 | 4,220 | 4,155 | 4,185 | +10 | +0.2% | 50,200 |
2019/10/23 | 4,135 | 4,175 | 4,080 | 4,175 | +80 | +2% | 49,600 |
2019/10/21 | 4,120 | 4,135 | 4,070 | 4,095 | -35 | -0.8% | 38,300 |
2019/10/18 | 4,165 | 4,215 | 4,115 | 4,130 | -20 | -0.5% | 47,500 |
2019/10/17 | 4,195 | 4,195 | 4,105 | 4,150 | -40 | -1% | 78,400 |
2019/10/16 | 4,215 | 4,245 | 4,175 | 4,190 | +35 | +0.8% | 80,400 |
2019/10/15 | 4,130 | 4,180 | 4,130 | 4,155 | +100 | +2.5% | 71,400 |
2019/10/11 | 4,080 | 4,080 | 4,030 | 4,055 | +5 | +0.1% | 43,600 |
2019/10/10 | 4,075 | 4,090 | 4,015 | 4,050 | -40 | -1% | 41,000 |
1301~
1350
件表示中 / 3684件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 304,500円 | +3.0% | +27.5% | 2.63% | 19.28倍 | 0.84倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
東和薬品 | 252,400円 | +15.0% | -7.3% | 2.77% | 8.28倍 | 0.78倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ゼリア新薬 | 231,200円 | +14.2% | +41.0% | 1.99% | 11.32倍 | 1.15倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ジーエヌアイ | 218,100円 | +21.7% | +999.9% | 0.00% | 9.08倍 | 3.00倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
杏林製薬 | 147,600円 | +3.2% | +4.5% | 3.52% | 16.96倍 | 0.65倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
市場注目の銘柄
チャート関連のコラム